NOT-DK-14-007: Notice of Correction to Award Budget in RFA-DK-13-018 "Consortium on Beta-cell Death and Survival (HIRN-CBDS) (UC4)"

Notice of Correction to Award Budget in RFA-DK-13-018 "Consortium on Beta-cell Death and Survival (HIRN-CBDS) (UC4)"

Notice Number: NOT-DK-14-007

Key Dates
Release Date: November 27, 2013

Related Announcements
RFA-DK-13-018

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice provides correction to the language used to describe the limitations on the Award Budget in RFA-DK-13-018 "Consortium on Beta-cell Death and Survival (HIRN-CBDS) (UC4)".

Part II. Section II. Award Information

Currently reads:

Award Budget

Application budgets are limited to $600,000 per year in direct costs. This limit is inclusive of any direct and F&A costs associated with consortium or subcontract agreements.

Modified to read:

Award Budget

Total costs should not exceed $900,000 per year for each of the 5 years of the award.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Olivier Blondel, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phone: (301) 451-7334
Email: [email protected]